Imaging of Pheochromocytoma and Paraganglioma.
DOTATATE
FDG
FDOPA
MIBG
paraganglioma
pheochromocytoma
somatostatin
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
received:
02
11
2020
accepted:
16
02
2021
entrez:
31
7
2021
pubmed:
1
8
2021
medline:
6
1
2022
Statut:
ppublish
Résumé
Imaging plays a critical role in the management of pheochromocytomas and paragangliomas and often guides treatment. The discovery of susceptibility genes associated with these tumors has led to better understanding of clinical and imaging phenotypes. Functional imaging is of prime importance because of its sensitivity and specificity in subtypes of pheochromocytoma and paraganglioma. Several radiopharmaceuticals have been developed to target specific receptors and metabolic processes seen in pheochromocytomas and paragangliomas, including
Identifiants
pubmed: 34330739
pii: jnumed.120.259689
doi: 10.2967/jnumed.120.259689
pmc: PMC8833868
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1033-1042Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Références
J Nucl Med. 2016 Feb;57(2):186-91
pubmed: 26564322
Eur J Nucl Med. 1991;18(3):191-8
pubmed: 1645665
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):982-93
pubmed: 17225119
Hum Pathol. 2019 Apr;86:66-75
pubmed: 30529752
Eur Radiol. 2016 Jun;26(6):1696-704
pubmed: 26427697
Anticancer Res. 2006 Mar-Apr;26(2B):1599-604
pubmed: 16619578
Eur J Endocrinol. 2018 May;178(5):431-437
pubmed: 29467230
Cancer Biother Radiopharm. 2009 Aug;24(4):469-75
pubmed: 19694582
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1784-91
pubmed: 26996779
J Nucl Med. 1980 Apr;21(4):349-53
pubmed: 7381563
Surgery. 2017 Jan;161(1):220-227
pubmed: 27865588
Clin Endocrinol (Oxf). 2008 Oct;69(4):580-6
pubmed: 18394015
Eur J Nucl Med Mol Imaging. 2003 May;30(5):689-94
pubmed: 12618904
J Nucl Med. 2007 Oct;48(10):1599-606
pubmed: 17873132
Eur J Nucl Med Mol Imaging. 2018 May;45(5):787-797
pubmed: 29204718
J Natl Cancer Inst. 2012 May 2;104(9):700-8
pubmed: 22517990
Endocr Relat Cancer. 2008 Mar;15(1):311-23
pubmed: 18310297
Clin Endocrinol (Oxf). 2008 Aug;69(2):181-8
pubmed: 18394016
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112-2137
pubmed: 31254038
N Engl J Med. 2002 May 9;346(19):1459-66
pubmed: 12000816
Nucl Med Mol Imaging. 2015 Jun;49(2):143-51
pubmed: 26085860
J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67
pubmed: 19864450
J Clin Endocrinol Metab. 1992 May;74(5):1082-9
pubmed: 1349024
J Clin Endocrinol Metab. 2001 Feb;86(2):685-93
pubmed: 11158032
J Nucl Med. 1985 Jun;26(6):576-85
pubmed: 2860214
Clin Cancer Res. 2015 Sep 1;21(17):3888-95
pubmed: 25873086
J Clin Endocrinol Metab. 2010 May;95(5):2023-37
pubmed: 20215394
J Clin Endocrinol Metab. 2011 Sep;96(9):2779-85
pubmed: 21752889
Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):494-504
pubmed: 24158184
Nucl Med Mol Imaging. 2011 Jun;45(2):125-31
pubmed: 24899991
J Med Imaging Radiat Oncol. 2017 Dec;61(6):745-752
pubmed: 28585398
Radiology. 1999 Jul;212(1):35-41
pubmed: 10405717
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2436-46
pubmed: 20644928
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1248-57
pubmed: 26637204
Endocr Pract. 2016 Mar;22(3):302-14
pubmed: 26523625
Nucl Med Commun. 2006 Jul;27(7):583-7
pubmed: 16794519
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1574-1582
pubmed: 29534198
Clin Endocrinol (Oxf). 2019 Jan;90(1):31-46
pubmed: 30303539
AJR Am J Roentgenol. 2016 Jun;206(6):1141-8
pubmed: 27011100
J Surg Oncol. 2015 Oct;112(5):486-91
pubmed: 26337393
J Clin Oncol. 2007 Jun 1;25(16):2262-9
pubmed: 17538171
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1144-53
pubmed: 22358431
Clin Endocrinol (Oxf). 2013 Aug;79(2):170-7
pubmed: 23230826
Int J Urol. 1999 Mar;6(3):119-24
pubmed: 10226821
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1588-1601
pubmed: 28547177
Ann Surg. 2019 Apr;269(4):741-747
pubmed: 29334561
Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Sep;134(4):243-248
pubmed: 27887852
J Nucl Med. 2019 Mar;60(3):369-376
pubmed: 30030341
J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30
pubmed: 19622618
AJR Am J Roentgenol. 2008 May;190(5):1163-8
pubmed: 18430826
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Front Oncol. 2019 Feb 22;9:53
pubmed: 30854332
Endocr Rev. 2017 Dec 1;38(6):489-515
pubmed: 28938417
J Clin Endocrinol Metab. 2010 Jun;95(6):2800-10
pubmed: 20371665
Clin Chem. 2011 Mar;57(3):411-20
pubmed: 21262951
Cancer Imaging. 2016 Aug 17;16(1):22
pubmed: 27535829
Nucl Med Commun. 2013 Dec;34(12):1141-9
pubmed: 24128899
Acta Radiol. 2018 Dec;59(12):1466-1474
pubmed: 29566550
J Nucl Med. 2009 Sep;50(9):1448-54
pubmed: 19690028
AJR Am J Roentgenol. 2018 May;210(5):1073-1078
pubmed: 29570377
Clin Endocrinol (Oxf). 2009 Jul;71(1):11-7
pubmed: 19138315
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):278-282
pubmed: 28918451
Radiographics. 2015 Mar-Apr;35(2):500-16
pubmed: 25763733
Eur J Clin Invest. 2014;44(3):325-332
pubmed: 24422786
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200
pubmed: 19915839
J Nucl Med. 2014 Feb;55(2):204-10
pubmed: 24379222
Clin Endocrinol (Oxf). 2018 Aug;89(2):139-147
pubmed: 29741215